Purchase Order HT940623P0231
Award Date 9/30/23
Potential Completion Date 10/1/27
Potential Value $61K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The $237,020.85 contract is for the delivery of blood bank reagents and consumables to support the VA's medical operations and healthcare services. The contract does not have a set-aside designation and is expected to be completed by...
- This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
- This is a firm-fixed price supply contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract, valued at $1,016,206.99, is for the delivery of consumable reagents used for blood typing, antibody screening, and identifying compatible blood products for transfusion. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods. The original...
- This federal contract award is for the delivery of blood bank reagents to support the operations of the Defense Health Agency (DHA) from June 13, 2024 to September 30, 2024. The $35,616.26 firm fixed price delivery order was awarded to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products and blood banking supplies. Immucor has previously held multiple award schedule contracts and other federal awards with agencies such as the Department of Veterans Affairs and Indian Health...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of automated blood testing equipment, reagents, and consumables. The contract, valued at $54,457.50, is for the provision of blood typing equipment and reagents. The contract does not have a set-aside designation. Immucor Inc. is a key supplier of specialized blood banking technologies and supplies that support medical testing and healthcare operations across federal...
- This is a firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract is for a base year plus four option years, with a ceiling value of $29,848.00, for the provision of blood bank reagents. The contract is issued under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and does not have a set-aside designation. Immucor is a key supplier of...
- This is a federal contract award by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The $73,426.14 firm fixed-price contract is for the supply and delivery of reagents. This contract is not set aside and is a delivery order issued under Immucor's existing General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and...
- This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
- This is a $91,866.32 firm fixed price delivery order contract awarded to Immucor Inc. by the Department of Defense's Bureau of Medicine and Surgery (BUMED). The contract is for the provision of blood reagents and is placed against Immucor's existing GSA Federal Supply Schedule (FSS) contract for in vitro diagnostics, reagents, and test kits. No set-aside was used for this award. Immucor is a leading provider of automated instrument-reagent systems, consumables, and services for blood transfusion...